On Aug. 28, 2020, Moderna confirmed that the Company is engaged in discussions with the Ministry of Health, Labour and Welfare of Japan (MHLW) to potentially purchase 40 million or more doses of mRNA-1273, Modernaﾒs vaccine candidate against COVID-19, to support Japanﾒs aim of providing vaccines to the public as soon as possible.

Under the terms of this arrangement, the vaccine would be supplied by Moderna, Inc. and distributed in Japan by Takeda Pharmaceutical beginning in the first half of 2021.